ILA — Island Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$96.17m
- AU$83.30m
- AU$0.28m
Australia's Island Pharma gains on clinical trial progress for dengue drug
Australia Stock Exchange release from ISLAND PHA : Island executes PEACH clinical study CRO agreement
Australia Stock Exchange release from ISLAND PHA : PRE_NR Ends: 09:16:11
Australia Stock Exchange release from ISLAND PHARMACEU : Change in substantial holding
Australia Stock Exchange release from ISLAND PHARMACEU : Appendix 3Y - Anna Lavelle
Australia Stock Exchange release from ISLAND PHARMACEU : Appendix 3Y - Albert Hansen
Australia Stock Exchange release from ISLAND PHARMACEU : Appendix 3Y - David Brookes
Australia Stock Exchange release from ISLAND PHARMACEU : Cleansing Notice
Australia Stock Exchange release from ISLAND PHARMACEU : Application for quotation of securities - ILA
Australia Stock Exchange release from ISLAND PHARMACEU : Results of Annual General Meeting
Australia Stock Exchange release from ISLAND PHARMACEU : Annual General Meeting MD Presentation
Australia Stock Exchange release from ISLAND PHARMACEU : Annual General Meeting Chair Address
Brief: Island Pharmaceuticals Says Clinical Trial Agreement Signed With Research Foundation For State University Of New York
Australia Stock Exchange release from ISLAND PHARMACEU : ISLA-101 Phase 2a clinical trial update
Australia Stock Exchange release from ISLAND PHARMACEU : PRE_NR Ends: 09:36:55
Australia Stock Exchange release from ISLAND PHARMACEU : PRE_NR Ends: 09:33:26
Australia Stock Exchange release from ISLAND PHARMACEU : Quarterly Activity Report & Appendix 4C
Australia Stock Exchange release from ISLAND PHARMACEU : Change in substantial holding
Australia Stock Exchange release from ISLAND PHARMACEU : Proposed issue of securities - ILA